CBLN1 and Alzheimer disease: The transcriptomic analysis of brain data showed the significant dysregulation of 20 out of 35 genes involved in the SM/Cer pathway in the case of AD patients, including sphingomyelin synthases and ceramide kinase, which were significantly dysregulated across multiple brain regions in the studied cohort.